CHD8
protein-codingchromodomain helicase DNA binding protein 8, the group of Small nucleolar RNA protein coding host genes
Gene summary
This gene encodes a member of the chromodomain-helicase-DNA binding protein family, which is characterized by a SNF2-like domain and two chromatin organization modifier domains. The encoded protein also contains brahma and kismet domains, which are common to the subfamily of chromodomain-helicase-DNA binding proteins to which this protein belongs. This gene has been shown to function in several processes that include transcriptional regulation, epigenetic remodeling, promotion of cell proliferation, and regulation of RNA synthesis. Allelic variants of this gene are associated with autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2016]
- HELSNF1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~70.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0005260
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0018940
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0001071
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
*CHD8* was first reported in relation to autosomal dominant autism spectrum disorder in 2012 (O'Roak et al., PMID: 22495309). *CHD8* encodes a member of the chromodomain helicase DNA-binding (CHD) protein family involved in chromatin remodeling. In addition to an increased likelihood of a diagnosis of autism spectrum disorder, individuals with pathogenic variants in *CHD8* have variable degrees of intellectual disability, an overgrowth phenotype with macrocephaly and increased height, dysmorphic facial features, and gastrointestinal problems (PMID: 24998929). We therefore decided to curate for the generic term complex neurodevelopmental disorder. Eight truncating variants (frameshift, nonsense) that have been reported in 8 probands in 4 publications (PMIDs: 22495309, 24998929, 26789910, 27824329) are included in this curation. Most variants are *de novo*; one individual inherited a *CHD8* variant from a heterozygous mother who had some autistic features but had not been clinically diagnosed. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by zebrafish and mouse models. In summary, there is definitive evidence supporting the relationship between *CHD8* and autosomal dominant complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on July 16, 2018 (SOP Version 5). As of February 2026, this record underwent administrative updates to include edits to the evidence summary and update scoring to be consistent with SOP Version 12. No new evidence was added, and the classification remains the same.
Inheritance Pattern: AD
Disease ID:MONDO:0014017
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Gastrointestinal; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CHD8 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001170629.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 18 | 300 | 13 | 331 | ||
| missense | 7 | 39 | 850 | 205 | 3 | 1104 |
| nonsense | 59 | 28 | 8 | 95 | ||
| start loss | 1 | 1 | ||||
| frameshift | 68 | 42 | 2 | 112 | ||
| splice donor/acceptor (+/-2bp) | 11 | 18 | 9 | 38 | ||
| Total | 145 | 127 | 888 | 505 | 16 | 1681 |
Highest pathogenic variant AF is 0.000013638928
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001164100.1 | 37 | MANE Select | |
| Ensembl | ENSP00000495240.1 | 37 | MANE Select | |
| RefSeq | NP_065971.2 | 37 | Standard | |
| Ensembl | ENSP00000406288.3 | 37 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| chd8 | Danio rerio | Structure: enteric neuron Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Wnt signaling pathway - Homo sapiens (human)
- Wnt Signaling Pathway
- Signaling by WNT
- Signal Transduction
- Deactivation of the beta-catenin transactivating complex
Biological Process
- negative regulation of transcription by RNA polymerase II
- in utero embryonic development
- brain development
- Wnt signaling pathway
- DNA duplex unwinding
Molecular Function
- p53 binding
- DNA binding
- DNA helicase activity
- chromatin binding
- protein binding
Cellular Component
- nucleus
- nucleoplasm
- protein-containing complex
- MLL1 complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000399982
- Coding exons
- 37
- Length
- 70933
- Individuals with no LoFs
- 124641
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 12
- Defined
- 124653
- p
- 0.0000481
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 5.95 | 806 | 1.44e+3 | 0.559 | 0.0000827 | 16853 |
| Missense (PolyPhen) | 166 | 516.11 | 0.32164 | 5933 | ||
| Synonymous | 1.03 | 473 | 502 | 0.941 | 0.0000254 | 5048 |
| Loss of Function | 10.1 | 5 | 129 | 0.0388 | 0.00000800 | 1415 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000066 | 0.000065 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000056 | 0.000056 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000027 | 0.000027 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: DNA helicase that acts as a chromatin remodeling factor and regulates transcription. Acts as a transcription repressor by remodeling chromatin structure and recruiting histone H1 to target genes. Suppresses p53/TP53-mediated apoptosis by recruiting histone H1 and preventing p53/TP53 transactivation activity. Acts as a negative regulator of Wnt signaling pathway by regulating beta-catenin (CTNNB1) activity. Negatively regulates CTNNB1- targeted gene expression by being recruited specifically to the promoter regions of several CTNNB1 responsive genes. Involved in both enhancer blocking and epigenetic remodeling at chromatin boundary via its interaction with CTCF. Acts as a suppressor of STAT3 activity by suppressing the LIF-induced STAT3 transcriptional activity. Also acts as a transcription activator via its interaction with ZNF143 by participating in efficient U6 RNA polymerase III transcription. {ECO:0000255|HAMAP- Rule:MF_03071, ECO:0000269|PubMed:17938208, ECO:0000269|PubMed:18378692}.;
- Disease
- DISEASE: Autism 18 (AUTS18) [MIM:615032]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:23160955, ECO:0000269|PubMed:26637798}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- LoFtool
- 0.121
- RVIS EVS
- -2.34
- RVIS percentile EVS
- 1.18
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- N
- Essential (gene trap)
- K
- Indispensability pred.
- E
- Indispensability score
- 0.948
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |